The technology would function through the introduction of smart monitoring devices for blood glucose and blood pressure.
The technology is an integrated health service, combining the concept of constant connectivity, advanced smart-device technology, remote chronic care management from home and continuum of care from the best specialists in the UAE.
The pilot study, performed to develop the technology, revealed promising improvement in diabetes management for 58 per cent of the patients following the monitoring regime, without any therapeutic variations.
The programme was inaugurated by Dr. Layla Al Marzouqi – Director of Health Regulation at the Dubai Health Authority (DHA); Dr. Azad Moopen – Founder, Chairman and Managing Director, Aster DM Healthcare; and Alisha Moopen – Executive Director and Chief Executive Officer, Hospitals & Clinics (GCC).
The integrated health service will empower patients to take control of their disease management through close monitoring of blood glucose and blood pressure reading, constant data management through a mobile app connected to a call centre and proactive patient outreach from Aster specialists for care.
“One of our constant efforts in the UAE, is to ensure that all our residents have access to quality healthcare and undertake the appropriate measures necessary to minimise the challenges associated with highly prevalent chronic diseases like diabetes and hypertension. Personalised and customised health services need to be accessible, affordable, and responsive.